USPTO 2015–2025 USPTO PatentsView US Corporation

Pacesetter, Inc.

USPTO PatentsView assignee record - 754 granted patents across 60 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

RSS updates for this company

The verdict

According to USPTO PatentsView, Pacesetter ranks #591 of 49,997 tracked US assignees by granted-patent volume, with 754 patents across 60 technology areas.

#591
of 49,997 US assignees by volume
Top 1%
by Innovation Score (66.2/100)
17.8
avg claims per patent
+16%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R591 · US Corporation #591 · 754 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

  • GRANTS-MID 754 grants
  • TOP-DECILE #591/49,997
  • PHOTO-FINISH adidas
  • CPC-WIDE A61N · 60 areas
  • INNOV-STRONG 66.2/100
  • CLAIMS-RICH 17.8 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-UP +16% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: adidas AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Pacesetter’s 66.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Pacesetter

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Pacesetter's Innovation Score is 66.2/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Pacesetter?

Each dot is one of Pacesetter’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Pacesetter’s own 17.8 claims/patent is ABOVE the 13.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Pacesetter vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 745750755760765770 0510152025 Granted patents (volume) Avg claims / patent Cochlear Limited - 768, 23.47CochlearMellanox Technologies, Ltd. - 766, 19.62MellanoxMediaTek Singapore Pte. Ltd. - 761, 17.77Mediatek Singapor…Hanon Systems - 758, 13.75Hanon Systemsadidas AG - 754, 12.75adidasMedline Industries, LP - 753, 10.3Medline IndustriesShenzhen Goodix Technology Co., Ltd. - 753, 17.31Shenzhen Goodix T…Spigen Korea Co., Ltd. - 749, 1.96Spigen KoreaPacesetter, Inc. - 754, 17.8Pacesetter
Pacesetter vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How Pacesetter's grant cadence moved

Between 2020–2024, Pacesetter, Inc. received 374 grants versus 322 in 2015–2019 (+16% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2023 at 88 grants and bottomed in 2017 at 50. Lead class A61N accounts for 80.8% of the portfolio across 60 subclasses. Volume neighbours: Cochlear Limited (#586) and Spigen Korea Co., Ltd. (#594).

Pacesetter's three-year grant acceleration

From 2019–2021 to 2022–2024, Pacesetter, Inc. moved from 201 to 229 grants (1.14x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #890. See the growth leaderboard.

Who files at Pacesetter's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Pacesetter holds 754 patents at rank #590, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Pacesetter

By rank, the assignees closest to #590 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Pacesetter's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Pacesetter, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Pacesetter ranks #4 of 1,943 assignees by patent count in that subclass.

Pacesetter's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

66 Top 1% higher than 99% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

405060708090 20152016201720182019202020212022202320242025 58
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Pacesetter, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 82 10.9%
2016 78 10.3%
2017 50 6.6%
2018 56 7.4%
2019 56 7.4%
2020 79 10.5%
2021 66 8.8%
2022 64 8.5%
2023 88 11.7%
2024 77 10.2%
2025partial year 58 7.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Pacesetter, Inc.'s patent record in context - here's where to go next.

  • Pacesetter, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 80.8% of its portfolio - see every assignee active in that class. Explore A61N
  • Ranked #591 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Pacesetter, Inc. against Cochlear Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 66.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.